CIENCIASMEDICASNEWS: NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death By 81% In Older Adults, Not Effective In Younger Patients - Health Policy Watch

martes, 30 de agosto de 2022

NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death By 81% In Older Adults, Not Effective In Younger Patients - Health Policy Watch

NEJM Study: Pfizer’s Paxlovid Reduces COVID-19 Death By 81% In Older Adults, Not Effective In Younger Patients - Health Policy Watch

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)